야간뇨의진단과치료 - 실제적접근 -
Reference 1. Choo MS, Ku JH, Park CH et al. Prevalence of Nocturia in a Korean Population Aged 40 to 89 Years. Neurourol Urodyn 2008; 27:60-64. 2. Weiss JP. Prevalence Of Nocturnal Polyuria In Nocturia. J Urol 2009;181 (Supplement): 538. Abstract 1504 presented at AUA 2009 3. Weiss JP, Blaivas JG, Stember DS et al. Nocturia in Adults: Etiology and Classification. Neurourol Urodyn 1998;17:467-472. 4. Van Kerrebroeck P, Abrams P, Chaikin D et al. The Standardisation of Terminology in Nocturia: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:179-83. 5. Vilhardt H. Basic pharmacology of desmopressin: A review. Drug Investigation 1990;2(Suppl 5):2-8. 6. The Committee for Establishment of the Clinical Guidelines for Nocturia of the Neurogenic Bladder Society. Clinical guidelines for nocturia. Int J Urol. 2010 May;17(5):397-409. 7. Robertson GL, Norgaard JP. Renal regulation of urine volume: potential implications for nocturia. BJU Int 2002;90(Suppl 3):7-10. 8. Asplund R. Diuresis pattern, plasma vasopressin and blood pressure in healthy elderly persons with nocturia and nocturnal polyuria. Netherlands J Med 2002;60:276-80. 9. Hammer M, Vilhardt H. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin. J Pharmacol Exp Ther 1985;234(3):754-60. 10. Williams TD, Dunger DB, Lyon CC, et al. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin: 1. Studies in adults and children. J Clin Endocrinol Metab 1986;63:129-32. 11. Rembratt A, Graugaard-Jensen C, Senderovitz T, et al. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years. Eur J Clin Pharmacol 2004;60:397-402. 12. Lose G, Lalos O, Freeman R, et al. Efficacy of desmopressin (Minirin) in the treatment of nocturia: A double-blind, placebo controlled study in women. Am J Obstet Gynecol 2003;189:1106-13. 13. Mattiasson A, Abrams P, van Kerrebroeck P, et al. Efficacy of desmopressin in the treatment of nocturia. A double-blind, placebo-controlled study in men. BJU Int 2002;89:855-62. 14. Lose G, Mattiasson A, Walter S, et al. Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol 2004;172:1021-1025 15. Rambratt A, Riis A, Norgaard JP. Desmopressin treatment in nocturia: an analysis of risk factors for hyponatremia. Neurourol Urodyn 2006;25:105-109 16. Bae JH, Oh MM, Shim KS, et al. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study. J Urol 2007;178:200-203 17. Asplund R, Sundberg B, Bengtsson P. Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose titration study. Br J Urol 1998;82:642-646 18. Vande Walle J, Stockner M, Raes A, et al. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf 2007;2:232-238 19. 0.1, 0.2mg 20. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000 May 25;342(21):1581-9 21. Brubaker L, FitzGerald MP. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J. 2007;18:737-741 22. Djavan B, Milani S, Davies J, et al. The Impact of Tamsulosin Oral Controlled AbsorptionSystem(OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study Eur Urol Suppl 2005;4:61-68 23. Yoong HF, Sundaram MB, Aida Z. Prevalence of nocturnal polyuria in patients with benign prostatic hyperplasia. Med J Malaysia. 2005 Aug;60(3):294-6 24. Van Kerrebroeck P, Rezapour M, Cortesse A, et al. Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study. Eur Urol 2007;52:221-229